Use access key #2 to skip to page content.
$24.26 0.32 (1.34%)
10/7/2008 4:02 PM

Forest Laboratories, Inc. (FRX)

CAPS Rating:
****

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.

View All Commentary (FRX)

Recs

0

Avatar biovestor (< 20) Submitted: 6/28/08 3:54 PM : Outperform Start Price: $33.38 FRX Score: -5.51

A mid-size specialty pharma company around $10 billion market cap also set to gain from potential approval of milnacipran by end of October 2007 for fibromyalgia (with partner Cypress Bio). Company's products focus mainly on neuro indications such as depression and Alzheimer's with a forward PE below 10.

Report this Post Replies: 0 | Reply

Featured Broker Partners